Pharmaceutical Firm Settles More SEC Bribery Charges

Posted 7/6/20

Swiss pharmaceutical firm Novartis AG agreed June 25, 2020, to pay the Securities and Exchange Commission (SEC) and Justice a total of $345 million to settle charges that it violated the Foreign …

This item is available in full to subscribers.

Please log in to continue

Log in